Internal Medicine · Arcadia, CA
NPI
1689694580
Since 2006
Specialty
Internal Medicine
Code 207R00000X
Group practices
0
Medicare group memberships
Hospitals
1
Hospital affiliations
650 W Duarte Rd Ste 208
Arcadia, CA, 91007
Phone (626) 446-1599
Medicare paid, 2024
$175K
2,420 services
Medicare patients, 2024
407
Average age 79
Drug cost, 2024
$2.0M
16,434 prescriptions
Company payments, 2025
$756
From 10 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Hongsheng Wei was code 99213 (office e&m - established), 1,223 times for 389 patients. In total Hongsheng Wei billed 2,420 services in 20 codes, and Medicare paid $175K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99213 Office E&M - Established | Office | 1,223 | 389 | $72.22 | $88K |
| 99232 Hospital E&M - Subsequent | Facility | 242 | 25 | $64.74 | $16K |
| G0439 Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 226 | 226 | $140.11 | $32K |
| G0444 Annual depression screening, 5 to 15 minutes | Office | 224 | 224 | $21.08 | $4,721 |
| G0442 Annual alcohol misuse screening, 5 to 15 minutes | Office | 203 | 203 | $21.08 | $4,280 |
| 99233 Hospital E&M - Subsequent | Facility | 46 | 28 | $97.48 | $4,484 |
| 99223 Hospital E&M - Initial | Facility | 44 | 31 | $142.38 | $6,265 |
| 99239 Hospital Discharge Management | Facility | 34 | 28 | $95.21 | $3,237 |
| G0438 Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 29 | 29 | $177.20 | $5,139 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 22 | 21 | $13.70 | $301 |
| 99204 Office E&M - New | Office | 19 | 19 | $117.34 | $2,229 |
| G0180 Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 13 | 13 | $46.09 | $599 |
By year: 2022 $167K for 2,072 services; 2023 $151K for 1,883 services; 2024 $175K for 2,420 services.
Medicare prescription drug claims, 2024
In 2024, the drug Hongsheng Wei prescribed most often to Medicare patients was Atorvastatin Calcium, with 1,248 prescriptions and refills. In total Hongsheng Wei wrote 16,434 Medicare prescriptions that cost $2.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Atorvastatin Calcium Generic | 1,248 | 2,759 | 319 | $11K |
| Amlodipine Besylate Generic | 1,077 | 2,180 | 244 | $5,133 |
| Metformin Hcl Generic | 514 | 1,047 | 107 | $2,842 |
| Losartan Potassium Generic | 496 | 1,085 | 120 | $3,979 |
| Clopidogrel Clopidogrel Bisulfate | 492 | 947 | 104 | $3,041 |
| Zolpidem Tartrate Generic | 460 | 564 | 122 | $1,574 |
| Levothyroxine Sodium Generic | 454 | 845 | 83 | $3,409 |
| Rosuvastatin Calcium Generic | 397 | 762 | 86 | $4,718 |
| Metoprolol Succinate Generic | 333 | 713 | 85 | $4,432 |
| Vascepa Icosapent Ethyl | 318 | 474 | 74 | $150K |
| Olmesartan Medoxomil Generic | 281 | 489 | 58 | $3,706 |
| Lorazepam Generic | 256 | 308 | 59 | $618 |
| Donepezil Hcl Generic | 227 | 401 | 53 | $2,891 |
| Glipizide Generic | 212 | 418 | 45 | $2,026 |
| Jardiance Empagliflozin | 207 | 332 | 40 | $183K |
Brand drugs: 2,594 claims; generic drugs: 13,659 claims; opioid claims: 66.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Hongsheng Wei $756 ($756 in general payments such as food, travel and fees) from 10 companies. The largest payer was Abbvie Inc. with $228.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 8 | $228 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $161 |
| Amgen Inc. AMGN | 4 | $96.1 |
| Novartis Pharmaceuticals Corporation NVS | 3 | $87.7 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 2 | $45.03 |
| GlaxoSmithKline, LLC. GSK | 2 | $44.19 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27.7 |
| Gilead Sciences, Inc. GILD | 1 | $24.13 |
| Pfizer Inc. PFE | 1 | $21.5 |
| Lilly USA, LLC LLY | 1 | $20.4 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.